JMP Securities analyst Patrick Walravens maintains C3.ai (NYSE:AI) with a Market Outperform and lowers the price target from $25 to $19.
‘Well-Established’ Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
RBC Capital markets initiated coverage on Bausch + Lomb Corp (NYSE:BLCO) with an Outperform rating and a $22 price target. The analysts see…